SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-028209
Filing Date
2010-03-25
Accepted
2010-03-25 15:11:37
Documents
3
Period of Report
2010-03-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c98372e8vk.htm 8-K 9561
2 EXHIBIT 99.1 c98372exv99w1.htm EX-99.1 9208
3 GRAPHIC c98372p9837201.gif GRAPHIC 4617
  Complete submission text file 0000950123-10-028209.txt   26882
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 10704407
SIC: 2835 In Vitro & In Vivo Diagnostic Substances